Veritas Asset Management LLP Bio Rad Laboratories, Inc. Transaction History
Veritas Asset Management LLP
- $9.54 Billion
- Q4 2024
A detailed history of Veritas Asset Management LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Veritas Asset Management LLP holds 976,827 shares of BIO stock, worth $251 Million. This represents 3.36% of its overall portfolio holdings.
Number of Shares
976,827
Previous 1,086,479
10.09%
Holding current value
$251 Million
Previous $364 Million
11.72%
% of portfolio
3.36%
Previous 3.03%
Shares
11 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$493 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$398 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$268 Million0.29% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$192 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$186 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.32B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...